Pamela J Hornby Selected Research

Glucagon-Like Peptide-2 Receptor

5/2011	The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease.
5/2010	GLP-2 receptor agonism ameliorates inflammation and gastrointestinal stasis in murine postoperative ileus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pamela J Hornby Research Topics

Disease

3	Obesity 01/2022 - 09/2010
2	Type 2 Diabetes Mellitus (MODY) 12/2020 - 01/2019
2	Weight Gain 01/2019 - 08/2006
2	Inflammation (Inflammations) 05/2010 - 01/2010
2	Colitis 08/2006 - 06/2006
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Communicable Diseases (Infectious Diseases) 12/2019
1	Body Weight (Weight, Body) 01/2019
1	Hyperglycemia 01/2019
1	Lipidoses 01/2019
1	Morbid Obesity 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2015
1	Disease Progression 01/2015
1	Dysbiosis 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Neoplasms (Cancer) 05/2011
1	Short Bowel Syndrome 05/2011
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2011
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2011
1	Ileus 05/2010
1	Hypoxia (Hypoxemia) 01/2010
1	Nausea 01/2010
1	Feeding and Eating Disorders (Eating Disorder) 01/2010
1	Vomiting 01/2010
1	Pneumonia (Pneumonitis) 09/2009
1	Diarrhea 08/2006
1	Pain (Aches) 04/2004
1	Asthma (Bronchial Asthma) 02/2004

Drug/Important Bio-Agent (IBA)

3	Hormones (Hormone)IBA 01/2019 - 05/2010
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2010
2	Insulin (Novolin)FDA Link 12/2020 - 01/2019
2	GlycogenIBA 12/2020 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2019
2	Pyruvic Acid (Pyruvate)IBA 12/2020 - 01/2019
2	Glucagon-Like Peptide-2 ReceptorIBA 05/2011 - 05/2010
2	CannabinoidsIBA 01/2010 - 08/2006
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2006 - 04/2004
1	EnzymesIBA 01/2022
1	indoleIBA 01/2022
1	KynurenineIBA 01/2022
1	propionic acid (potassium propionate)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 12/2020
1	Aconitic Acid (Aconitate)IBA 12/2020
1	Citric Acid (Citrate)FDA LinkGeneric 12/2020
1	Aligeron (AS 2)IBA 01/2019
1	camostatIBA 01/2019
1	4-(4-guanidinobenzoyloxy)phenylacetic acidIBA 01/2019
1	fibroblast growth factor 21IBA 01/2019
1	Branched-Chain Amino AcidsIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Immunoglobulin G (IgG)IBA 05/2010
1	Glucagon-Like Peptide 2IBA 05/2010
1	Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA 09/2009
1	Cholinergic Agents (Cholinergics)IBA 09/2009
1	Cannabinoid Receptor AgonistsIBA 08/2006
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 08/2006
1	Dextran SulfateIBA 08/2006
1	Dihydrotachysterol (AT 10)IBA 08/2006
1	CarbamatesIBA 06/2006
1	AntigensIBA 02/2004

Therapy/Procedure

1	Therapeutics 12/2019
1	Total Parenteral Nutrition 05/2011
1	Oral Administration 06/2006